CoChat

SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1

Open access
Lan, Fan, Cacicedo, Jose M., Ruderman, Neil, Ido, Yasuo · 2008 · Journal of Biological Chemistry

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

SIRT1, a histone/protein deacetylase, and AMP-activated protein kinase (AMPK) are key enzymes responsible for longevity and energy homeostasis. We examined whether a mechanistic connection exists between these molecules that involves the major AMPK kinase LKB1. Initial studies demonstrated that LKB1 is acetylated in cultured (HEK293T) cells, mouse white adipose tissue, and rat liver. In the 293T cells, SIRT1 overexpression diminished lysine acetylation of LKB1 and concurrently increased its activity, cytoplasmic/nuclear ratio, and association with the LKB1 activator STRAD. In contrast, short hairpin RNA for SIRT1, where studied, had opposite effects on these parameters. Mass spectrometric analysis established that acetylation of LKB1 occurs on multiple, but specific, lysine residues; however, only mutation of lysine 48 to arginine, which mimics deacetylation, reproduced all of the effects of activated SIRT1. SIRT1 also affected downstream targets of LKB1. Thus its overexpression increased AMPK and acetyl-CoA carboxylase phosphorylation, and conversely, RNA interference-mediated SIRT1 knockdown reduced AMPK phosphorylation and that of another LKB1 target MARK1. Consistent with the results in cultured cells, total LKB1 lysine acetylation was decreased by 60% in the liver of 48-h starved rats compared with starved-refed rats, and this was associated with modest but significant increases in both LKB1 and AMPK activities. These results suggest that LKB1 deacetylation is regulated by SIRT1 and that this in turn influences its intracellular localization, association with STRAD, kinase activity, and ability to activate AMPK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m805711200

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 LKB1 acetylation and the effects of SIRT1. A, lysine acetylation of an exogenously expressed LKB1. Myc-tagged LKB1 expressed in HEK293T cells wasimmunoprecipitated with native ( N ) and covalently linked ( C ) anti-Myc antibody-protein A beads. B, modulation of LKB1 acetylation by SIRT1 in 293T cells. Plasmids expressing GST-LKB1 were transfected into HEK293T cells together with pcDNA or shRNA lentivirus for control, SIRT1 WT, or H355Y plasmid (0.5 𝛍 g) or shRNA for SIRT1 lentivirus. In addition, some cells were treated with 50-100 𝛍 M resveratrol for 0.5-1 h. The cells were harvested for Western blotting to quantify LKB1 acetylation. *, p < 0.05 versus control. Number of samples are shown in parentheses . C, direct deacetylation of GST-LKB1 by SIRT1 in vitro . Purified GST-LKB1wasincubatedinaSIRT1reactionbuffercontaining1 𝛍 l of recombinant SIRT1 solution with/without 0.6 mM NAD + at 30 °C for 30 min ( n = 6). D, SIRT1 expression levels affect STRAD association with LKB1. The 293T cells were transfected with SIRT1 plasmid or shRNA for sirt1 . STRAD binding to LKB1 was assessed by calculating the STRAD to LKB1 ratio and is expressed as percent of the ratio in control cells (*, p < 0.05 versus C . Number of samples are in parenthesis ). E and F, effects of SIRT1 overexpression on LKB1 activity ( E ) and phosphorylation ( F ). E, 293Tcells were transfected with the 0.2 𝛍 gofSIRT1plasmid. LKB1activity was assessed in LKB1-immunoprecipitated samples (*, p < 0.005 versus control (pcDNA) plasmid, n = 3). The H355Y mutant did not increase LKB1 activity. F, 293T cells were co-transfected with 0.2 𝛍 g of SIRT1 and 0.5 𝛍 g of GSTl-LKB1 plasmids and blotted with the indicated antibodies.
FIGURE 1 LKB1 acetylation and the effects of SIRT1. A, lysine acetylation of an exogenously expressed LKB1. Myc-tagged LKB1 expressed in HEK293T cells wasimmunoprecipitated with native ( N ) and covalently linked ( C ) anti-Myc antibody-protein A beads. B, modulation of LKB1 acetylation by SIRT1 in 293T cells. Plasmids expressing GST-LKB1 were transfected into HEK293T cells together with pcDNA or shRNA lentivirus for control, SIRT1 WT, or H355Y plasmid (0.5 𝛍 g) or shRNA for SIRT1 lentivirus. In addition, some cells were treated with 50-100 𝛍 M resveratrol for 0.5-1 h. The cells were harvested for Western blotting to quantify LKB1 acetylation. *, p < 0.05 versus control. Number of samples are shown in parentheses . C, direct deacetylation of GST-LKB1 by SIRT1 in vitro . Purified GST-LKB1wasincubatedinaSIRT1reactionbuffercontaining1 𝛍 l of recombinant SIRT1 solution with/without 0.6 mM NAD + at 30 °C for 30 min ( n = 6). D, SIRT1 expression levels affect STRAD association with LKB1. The 293T cells were transfected with SIRT1 plasmid or shRNA for sirt1 . STRAD binding to LKB1 was assessed by calculating the STRAD to LKB1 ratio and is expressed as percent of the ratio in control cells (*, p < 0.05 versus C . Number of samples are in parenthesis ). E and F, effects of SIRT1 overexpression on LKB1 activity ( E ) and phosphorylation ( F ). E, 293Tcells were transfected with the 0.2 𝛍 gofSIRT1plasmid. LKB1activity was assessed in LKB1-immunoprecipitated samples (*, p < 0.005 versus control (pcDNA) plasmid, n = 3). The H355Y mutant did not increase LKB1 activity. F, 293T cells were co-transfected with 0.2 𝛍 g of SIRT1 and 0.5 𝛍 g of GSTl-LKB1 plasmids and blotted with the indicated antibodies.CC-BY · From the PDF
FIGURE 2 Identification of key lysines regulated by deacetylation in LKB1. A, LC-MS/MS and MALDI-TOF analyses revealed that LKB1 is acetylated on a number of lysine residues in each of its three domains. The asterisks indicate the positions of the acetylated lysines. The analysis was repeated six times, and the results for acetylation modification were compiled (see supplemental Fig. S2 for detail). B, identification of the domain on LKB1 that interacts with endogenous SIRT1. Plasmids expressing the indicated GST-tagged fragments of LKB1 and SIRT1 were co-transfected into HEK293T cells. GST-LKB1 fragments were pulled down with GSH beads and blotted with GST and SIRT1 antibodies. A strong association was observed between the N-terminal catalytic domain (amino acids 45-90) of LKB1 and SIRT1. C, effects of point mutations of lysine to arginine at various sites between 44 and 97. N-terminal lysine residues were systematically mutated to the deacetylation mimic arginine and expressed in HEK293T cells. Only Lys-48 showed enhanced phosphorylation of Ser-428 and Thr-336 ( n = 4). D and E, effects of the arginine point mutation at Lys-48 on SIRT1-induced phosphorylation of AMPK, LKB1 Thr-336, and LKB1 activity. SIRT1 overexpression (2 𝛍 g) markedly increased the phosphorylation of Thr-336 on wild type ( WT ) LKB1. In contrast, phosphorylation of Thr-336 was increased basally but was insensitive to SIRT1 overexpression in the K48R mutant. A similar trend was observed in AMPK phosphorylation. No changes were observed in KD-expressing cells. Numbers refer to fold-changes in density of a band compared with that in control cells ( D ). E, activity of GST-K48R LKB1 expressed in 293T cells were 2-fold higher than wild type (*, p < 0.05, n = 4). F, effects of SIRT1 overexpression on cellular distribution of K48R LKB1. Plasmids expressing GFP-tagged LKB1 harboring the indicated mutations were transfected with or without SIRT1 into HEK293T cells. SIRT1 overexpression increased the cytosol/nuclear ratio of WT LKB1, but failed to do so in the K48Q LKB1 mutant. WhenK48Rwasused, the cytosolic distribution of LKB1 was already increased (*, p < 0.05 versus WTLKB1notinfected with SIRT1, n = 15-20), and it was not increased further by SIRT1 overexpression.
FIGURE 2 Identification of key lysines regulated by deacetylation in LKB1. A, LC-MS/MS and MALDI-TOF analyses revealed that LKB1 is acetylated on a number of lysine residues in each of its three domains. The asterisks indicate the positions of the acetylated lysines. The analysis was repeated six times, and the results for acetylation modification were compiled (see supplemental Fig. S2 for detail). B, identification of the domain on LKB1 that interacts with endogenous SIRT1. Plasmids expressing the indicated GST-tagged fragments of LKB1 and SIRT1 were co-transfected into HEK293T cells. GST-LKB1 fragments were pulled down with GSH beads and blotted with GST and SIRT1 antibodies. A strong association was observed between the N-terminal catalytic domain (amino acids 45-90) of LKB1 and SIRT1. C, effects of point mutations of lysine to arginine at various sites between 44 and 97. N-terminal lysine residues were systematically mutated to the deacetylation mimic arginine and expressed in HEK293T cells. Only Lys-48 showed enhanced phosphorylation of Ser-428 and Thr-336 ( n = 4). D and E, effects of the arginine point mutation at Lys-48 on SIRT1-induced phosphorylation of AMPK, LKB1 Thr-336, and LKB1 activity. SIRT1 overexpression (2 𝛍 g) markedly increased the phosphorylation of Thr-336 on wild type ( WT ) LKB1. In contrast, phosphorylation of Thr-336 was increased basally but was insensitive to SIRT1 overexpression in the K48R mutant. A similar trend was observed in AMPK phosphorylation. No changes were observed in KD-expressing cells. Numbers refer to fold-changes in density of a band compared with that in control cells ( D ). E, activity of GST-K48R LKB1 expressed in 293T cells were 2-fold higher than wild type (*, p < 0.05, n = 4). F, effects of SIRT1 overexpression on cellular distribution of K48R LKB1. Plasmids expressing GFP-tagged LKB1 harboring the indicated mutations were transfected with or without SIRT1 into HEK293T cells. SIRT1 overexpression increased the cytosol/nuclear ratio of WT LKB1, but failed to do so in the K48Q LKB1 mutant. WhenK48Rwasused, the cytosolic distribution of LKB1 was already increased (*, p < 0.05 versus WTLKB1notinfected with SIRT1, n = 15-20), and it was not increased further by SIRT1 overexpression.CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Image 4
CC-BY · From the PDF
FIGURE 5 ProposedmechanismofLKB1activationbySIRT1. Activation of LKB1andLKB1targetmolecules by SIRT1, proposed mechanism. Factors that activate SIRT1 lead to deacetylation of one (Lys-48) or more key lysine residuesonLKB1.ThisinturnenhancesLKB1bindingtoSTRADandMO25,which increases its kinase activity, and leads to the phosphorylation and activation of AMPK, MARK1, and possibly other LKB1 targets. The scheme assumes that LKB1 acetylation by SIRT1 occurs in the nucleus and that this facilitates LKB1 movement to the cytoplasm by binding to STRAD. Not shown is that the activation of LKB1 by STRAD also leads to LKB1 phosphorylation at Ser-428 and Thr-336 (see text). (* = activated enzyme.)
FIGURE 5 ProposedmechanismofLKB1activationbySIRT1. Activation of LKB1andLKB1targetmolecules by SIRT1, proposed mechanism. Factors that activate SIRT1 lead to deacetylation of one (Lys-48) or more key lysine residuesonLKB1.ThisinturnenhancesLKB1bindingtoSTRADandMO25,which increases its kinase activity, and leads to the phosphorylation and activation of AMPK, MARK1, and possibly other LKB1 targets. The scheme assumes that LKB1 acetylation by SIRT1 occurs in the nucleus and that this facilitates LKB1 movement to the cytoplasm by binding to STRAD. Not shown is that the activation of LKB1 by STRAD also leads to LKB1 phosphorylation at Ser-428 and Thr-336 (see text). (* = activated enzyme.)CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 915

Metadata

Authors
Lan, F., Cacicedo, J. M., Ruderman, N., & Ido, Y.
Affiliations
Boston University (US)
Corresponding author
Ido, Yasuo
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2008-10
Volume
283
Issue
41
Pages
27628-27635
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2015022497
Cited by
825
References
22
Citations by year
2026: 27 · 2025: 36 · 2024: 54 · 2023: 47 · 2022: 56 · 2021: 54 · 2020: 53 · 2019: 36 · 2018: 48 · 2017: 60 · 2016: 45 · 2015: 43 · 2014: 53 · 2013: 53 · 2012: 38
FWCI
16.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk019514-35, DK 19514)
  • National Heart, Lung, and Blood Institute (P01 HL08758)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-19514)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Keywords
SIRT1, LKB1, protein acetylation, deacetylation, AMPK, STRAD, cytosolic localization, kinase activity, acetyl-CoA carboxylase, MARK1, energy homeostasis, fasting, liver, white adipose tissue, longevity
MeSH terms
AMP-Activated Protein Kinase Kinases, Acetylation, Animals, Cell Nucleus, Cytosol, Enzyme Activation, Humans, Liver, Starvation, Rats, Sprague-Dawley, Protein Serine-Threonine Kinases, Cyclic AMP-Dependent Protein Kinases, Active Transport, Cell Nucleus, Adaptor Proteins, Vesicular Transport, RNA Interference, Sirtuins, Cell Line, Tumor, Mice, Rats, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.